Submitted by Anonymous (not verified) on 4 December 2023 - 11:18
Opinion/decision on a Paediatric investigation plan (PIP): (E)-4-[(5-Phenyl-1,3,4-thiadiazol-2-yl)oxy]-1-azoniatricyclo[3.3.1.13,7] decane 3,4-dicarboxy-3-hydroxybutanoate hydrate (ABT-126), decision type: , therapeutic area: , PIP number: P/0081/2014
Source: